Role of Methionine Oxidation in the Progression of Oxidative Stress and Age-Related Diseases

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Aberrant Oxidation of Biomolecules".

Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 1769

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA
Interests: aging; oxidative stress; methionine oxidation; methionine sulfoxide reductase; neurodegenerative diseases; Alzheimer’s disease

Special Issue Information

Dear Colleagues,

Oxidative stress in biological systems may lead to the oxidation of methionine of both proteins and of the free amino acid methionine. The resulting methionine sulfoxide (MetO) moiety exists in two enantiomer forms: S-MetO and R-MetO, which can be enzymatically reduced to methionine through the methionine sulfoxide reductase (Msr) system (comparising of MsrA and MsrB, respectively). Oxidation of methionine residues of proteins may cause changes in the structure and function of the targeted proteins. In turn, these changes may foster the development of cellular and extracellular abnormalities that are associated with age-related diseases. The ability of an organism to reduce or degrade the MetO-containg proteins contributes to its cellular antioxidant capacity that may also affect its survival. Thus, the interaction between the Msr and the protein degradation systems, together with oxidative-stress-related signaling, play an important role in determining the redox and disease state of a cell/organism. The current Special Issue aims to gather both original and review articles that describe recent advances in scientific knowledge linked to methionine oxidation, such as function of age and conditions of oxidative stress. It is hoped that a better understanding of the physiological involvement of methionine oxidation and reduction in a living cell will foster the development of novel treatments to age and oxidative-stress-associated diseases.

Dr. Jackob Moskovitz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxidative stress
  • methionine oxidation
  • aging
  • post-translation modification
  • methionine sulfoxide
  • methionine sulfoxide reductase

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

18 pages, 2451 KiB  
Article
Methionine Sulfoxide Reductases Suppress the Formation of the [PSI+] Prion and Protein Aggregation in Yeast
by Jana Schepers, Zorana Carter, Paraskevi Kritsiligkou and Chris M. Grant
Antioxidants 2023, 12(2), 401; https://doi.org/10.3390/antiox12020401 - 07 Feb 2023
Viewed by 1513
Abstract
Prions are self-propagating, misfolded forms of proteins associated with various neurodegenerative diseases in mammals and heritable traits in yeast. How prions form spontaneously into infectious amyloid-like structures without underlying genetic changes is poorly understood. Previous studies have suggested that methionine oxidation may underlie [...] Read more.
Prions are self-propagating, misfolded forms of proteins associated with various neurodegenerative diseases in mammals and heritable traits in yeast. How prions form spontaneously into infectious amyloid-like structures without underlying genetic changes is poorly understood. Previous studies have suggested that methionine oxidation may underlie the switch from a soluble protein to the prion form. In this current study, we have examined the role of methionine sulfoxide reductases (MXRs) in protecting against de novo formation of the yeast [PSI+] prion, which is the amyloid form of the Sup35 translation termination factor. We show that [PSI+] formation is increased during normal and oxidative stress conditions in mutants lacking either one of the yeast MXRs (Mxr1, Mxr2), which protect against methionine oxidation by reducing the two epimers of methionine-S-sulfoxide. We have identified a methionine residue (Met124) in Sup35 that is important for prion formation, confirming that direct Sup35 oxidation causes [PSI+] prion formation. [PSI+] formation was less pronounced in mutants simultaneously lacking both MXR isoenzymes, and we show that the morphology and biophysical properties of protein aggregates are altered in this mutant. Taken together, our data indicate that methionine oxidation triggers spontaneous [PSI+] prion formation, which can be alleviated by methionine sulfoxide reductases. Full article
Show Figures

Figure 1

Back to TopTop